189 related articles for article (PubMed ID: 3147663)
1. Human trials of AIDS vaccines: novel means of passive and active immunotherapy.
Dalgleish AG
AIDS; 1988; 2 Suppl 1():S129-31. PubMed ID: 3147663
[No Abstract] [Full Text] [Related]
2. Vaccines and immunology. Overview.
Laurence J
AIDS; 1988; 2 Suppl 1():S91-4. PubMed ID: 2852505
[No Abstract] [Full Text] [Related]
3. Human trials of experimental AIDS vaccines: recombinant envelope proteins.
Snart RS
AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544
[No Abstract] [Full Text] [Related]
4. Antigenic structures recognized by T cells: towards the rational design of an AIDS vaccine.
Cease KB; Berzofsky JA
AIDS; 1988; 2 Suppl 1():S95-101. PubMed ID: 3147685
[No Abstract] [Full Text] [Related]
5. Second AIDS trial.
Ezzell C
Nature; 1988 Jan; 331(6154):290. PubMed ID: 2829025
[No Abstract] [Full Text] [Related]
6. Human trials go-ahead for the AIDS vaccine with a difference.
Newmark P
Nature; 1988 Apr; 332(6167):770. PubMed ID: 3282175
[No Abstract] [Full Text] [Related]
7. [A potential AIDS vaccine tester].
Fortschr Med; 1988 Jul; 106(22):14-5. PubMed ID: 2851511
[No Abstract] [Full Text] [Related]
8. Prospects for a vaccine against HIV.
Ada G
Nature; 1989 Jun; 339(6223):331-2. PubMed ID: 2725655
[No Abstract] [Full Text] [Related]
9. Phase I trial of potential AIDS vaccine commences.
Oncology (Williston Park); 1991 May; 5(5):182. PubMed ID: 1832002
[No Abstract] [Full Text] [Related]
10. Use of vaccinia virus vectors for development of AIDS vaccines.
Moss B
AIDS; 1988; 2 Suppl 1():S103-5. PubMed ID: 3147660
[No Abstract] [Full Text] [Related]
11. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I;
J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661
[TBL] [Abstract][Full Text] [Related]
12. [AIDS vaccines. Is optimism justified?].
Fortschr Med; 1989 Jul; 107(21):13. PubMed ID: 2767597
[No Abstract] [Full Text] [Related]
13. Prototype AIDS vaccine works in monkeys.
J Pract Nurs; 1990 Mar; 40(1):6-7. PubMed ID: 2329537
[No Abstract] [Full Text] [Related]
14. Part of AIDS virus is patented.
Sun M
Science; 1988 Feb; 239(4843):970. PubMed ID: 2830668
[No Abstract] [Full Text] [Related]
15. The prevention of maternal-fetal HIV-1 infection through passive antibody products (HIVIG) and active immunization (AIDS vaccines).
Lambert JS
Pediatr AIDS HIV Infect; 1995 Oct; 6(5):300-2. PubMed ID: 11361396
[No Abstract] [Full Text] [Related]
16. Troublesome trials for AIDS vaccines.
Ezzell C
Nature; 1987 Dec 24-31; 330(6150):687. PubMed ID: 3320754
[No Abstract] [Full Text] [Related]
17. [AIDS--possibilities for vaccine and antiviral therapy].
Grinde B; Hungnes O; Tjøtta E
Tidsskr Nor Laegeforen; 1988 Jun; 108(17-18):1413-5. PubMed ID: 3388373
[No Abstract] [Full Text] [Related]
18. FDA committee raises AIDS vaccine hurdles.
Cohen J
Science; 1991 Nov; 254(5035):1105. PubMed ID: 1683494
[No Abstract] [Full Text] [Related]
19. Immunotherapy of AIDS.
Dalgleish AG
Curr Opin Biotechnol; 1992 Dec; 3(6):650-5. PubMed ID: 1369121
[TBL] [Abstract][Full Text] [Related]
20. Is an effective HIV vaccine feasible?
Cohen J
Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
